ライフサイエンスコーパス: molecular pharmacology

1 eaching applications in drug development and molecular pharmacology.

2 major goal in the field of neuroscience and molecular pharmacology.

3 ted quinoline drugs may have quite different molecular pharmacology.

4 m conflicting data in crystal structures and molecular pharmacology.

5 ignpost for an era spanning over 40 years in molecular pharmacology.

6 grate large databases on gene expression and molecular pharmacology.

7 he article by Cassel et al. in this issue of Molecular Pharmacology, address this question and demons

8 976) in this issue of Molecular Pharmacology addresses whether this constituti

9 tribution by Micheva et al. in this issue of Molecular Pharmacology adds to our understanding of the

10 erential binding to a given target, detailed molecular pharmacology analysis accurately predicts util

11 By combining molecular pharmacology and genetic tools in INS-1E cells

12 Molecular pharmacology and mutagenesis studies indicate

13 detection will facilitate exploration of the molecular pharmacology and plasticity of exocytosis at m

14 aging will facilitate the exploration of the molecular pharmacology and plasticity of exocytosis at M

15 optogenetics, whole-cell electrophysiology, molecular pharmacology and single cell RT-PCR in mice.

16 The molecular pharmacology and stoichiometry of this binding

17 coma research, including molecular genetics, molecular pharmacology, and the search for novel antigla

18 In this issue of Molecular Pharmacology, Andreeva et al. (p.

19 In this issue of Molecular Pharmacology, Bauer et al. (p.

20 The studies in this issue of Molecular Pharmacology by Milojevic et al. merge these t

21 In this issue of Molecular Pharmacology, Dong et al. (p.

22 In this issue of Molecular Pharmacology, Emanuel et al. report on a tyros

23 -atomic resolution and have great promise in molecular pharmacology, especially in the context of map

24 cular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allost

25 In this issue of Molecular Pharmacology, Groot-Kormelink et al. (page 559

26 In this issue of Molecular Pharmacology, Hahn et al. (p.

27 The substantial impact that Molecular Pharmacology has had on the field of pharmacol

28 effectors through heterotrimeric G-proteins, molecular pharmacology has probed the basic organization

29 This issue of Molecular Pharmacology includes a study (p.

30 This issue of Molecular Pharmacology is dedicated to Dr.

31 Although its molecular pharmacology is multifarious, efavirenz's prev

32 A long-held tenet of molecular pharmacology is that canonical signal transduc

33 One of the goals of molecular pharmacology is to understand the machinery th

34 In the study published in this issue of Molecular Pharmacology, Kohout et al. (p.

35 In this issue of Molecular Pharmacology, Kundakovic et al. (p.

36 Two articles in recent issues of Molecular Pharmacology, Lane et al. and Galandrin and Bo

37 In an article presented in this issue of Molecular Pharmacology, Lim et al. (p.

38 In the current issue of Molecular Pharmacology, Liu et al. (p.

39 In this issue of Molecular Pharmacology, Luo et al. (p.

40 In this issue of Molecular Pharmacology, Luo et al. present a study emplo

41 In this issue of Molecular Pharmacology, Meyn et al. (p.

42 s has provided new insights into the complex molecular pharmacology of 17AAG and suggested new genes

43 that underscores the need to understand the molecular pharmacology of a compound's activity, includi

44 t the first comprehensive examination of the molecular pharmacology of BK channels.

45 tool for unraveling the cellular biology and molecular pharmacology of both naturally occurring and s

46 ur understanding of anticancer drugs and the molecular pharmacology of cancer.

47 dition to providing useful insights into the molecular pharmacology of CYC202 in human cancer cells,

48 We therefore studied the molecular pharmacology of CYC202 in human colon cancer c

49 re we describe the discovery, synthesis, and molecular pharmacology of delta-opioid receptor-selectiv

50 will highlight how our understanding of the molecular pharmacology of ER ligands has been utilized i

51 ng could provide valuable information on the molecular pharmacology of established and novel drugs.

52 Further understanding of the molecular pharmacology of failing synapses in Alzheimer

53 The molecular pharmacology of inhalational anesthetics remai

54 ssing and strand transfer as well as for the molecular pharmacology of integrase inhibitors.

55 However, the molecular pharmacology of ligand binding to CXCR3 altern

56 ell cycle may also help us to understand the molecular pharmacology of microtubule-active drugs.

57 re useful pharmacological tools to probe the molecular pharmacology of the delta receptor and to expl

58 10 years, and consider our knowledge of the molecular pharmacology of the drug in the context of cli

59 t the most extensive characterization of the molecular pharmacology of the most widely used CB2R liga

60 Further characterization of the molecular pharmacology of these and analogous compounds

61 information necessary for understanding the molecular pharmacology of these receptors.

62 information necessary for understanding the molecular pharmacology of this receptor, thus underlinin

63 In this issue of Molecular Pharmacology, Oliveras-Reyes et al. (p.

64 A study in this issue of Molecular Pharmacology on agonist-induced internalizatio

65 In this issue of Molecular Pharmacology, Ou and Gean (p.

66 A remarkable new article in this issue of Molecular Pharmacology (p.

67 on in light of a new report in this issue of Molecular Pharmacology (p.

68 An article presented in this issue of Molecular Pharmacology (p.

69 the article by Zhang et al. in this issue of Molecular Pharmacology (p.

70 In this issue of Molecular Pharmacology, Pannacione et al. provide eviden

71 ses in the cell but remains a major focus of molecular pharmacology research.

72 In this issue of Molecular Pharmacology, Stirone et al. (p.

73 Mutagenesis and molecular pharmacology studies revealed that TBPB activa

74 on two articles in the October 2015 issue of Molecular Pharmacology that investigate the role of mu-o

75 In this issue of Molecular Pharmacology, the work by Culmsee et al. (p.

76 true to the original goals for the journal, Molecular Pharmacology today remains an outstanding venu

77 s Perspective, former and current editors of Molecular Pharmacology, together with the guest editors

78 In this issue of Molecular Pharmacology, Trankle et al. (p.

79 A paradigm in molecular pharmacology was defined by design of rapid-ac

80 Integration of the principles of molecular pharmacology with contemporary high-throughput

81 In an article presented in this issue of Molecular Pharmacology, Yacoub et al. (p.

82 An article in this issue of Molecular Pharmacology (Yost et al., p.

83 In this issue of Molecular Pharmacology, Zaher et al. (p.

84 In this issue of Molecular Pharmacology, Zhang et al. (p.